Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Search results for:

physostigmine

physostigmine
  • Formulary
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Antilirium SOLUTION, INJECTABLE 1 mg/mL      
Anticholium SOLUTION, INJECTABLE 2 mg/5 mL      
VIEW MORE Parasympathomimetic (Cholinergic) Agents
Comments:

Physostigmine is no longer commercially available as 2 mg/2 mL. (Updated April 2023)

 

Temporary importation of 2 mg/5 mL product approved by FDA. (Updated November 2023)

 

Shortage Strategy (supply exhausted as of May 2026):

In the event that physostigmine is unavailable, consider use of rivastigmine orally/enterally [see anticholinergic toxicity for dosing strategies] in addition to supportive care.

Last updated: May. 13, 2026






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved